Patent details

EP2935303 Title: 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV

Basic Information

Publication number:
EP2935303
PCT Application Number:
US2013076740
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138644034
PCT Publication Number:
WO2014100505
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV
French Title of Invention:
4'-FLUORO-NUCLÉOSIDES, 4'-FLUORO-NUCLÉOTIDES ET LEURS ANALOGUES POUR LE TRAITEMENT DU VHC
German Title of Invention:
4'-FLUOR-NUKLEOSIDE, 4'-FLUOR-NUKLEOTIDE UND ANALOGA DAVON ZUR BEHANDLUNG VON HCV
SPC Number:

Dates

Filing date:
19/12/2013
Grant date:
17/02/2021
EP Publication Date:
28/10/2015
PCT Publication Date:
26/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/02/2021
EP B1 Publication Date:
17/02/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/12/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/02/2021
 
 

Name:
Janssen BioPharma, Inc.
Address:
260 E. Grand Ave., 2nd Floor, South San Francisco, CA 94080, United States (US)

Agent

Name:
ARONOVA S.A.
From:
30/03/2021
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
BEIGELMAN, Leonid
Address:
United States (US)

2

Name:
WANG, Guangyi
Address:
United States (US)

3

Name:
SMITH, David, Bernard
Address:
United States (US)

Priority

1

Priority Number:
201261745466 P
Priority Date:
21/12/2012
Priority Country:
United States (US)

2

Priority Number:
201361890125 P
Priority Date:
11/10/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/7068; A61K 31/7072; A61K 31/7076; A61K 31/708; A61P 31/14; C07H 19/067; C07H 19/073; C07H 19/10; C07H 19/167; C07H 19/173; C07H 19/20; C07H 19/213;

Publication

European Patent Bulletin

Issue number:
202107
Publication date:
17/02/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/12/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
07/04/2021 Outgoing Correspondence 1
30/03/2021 Power Of Attorney 1